Format

Send to

Choose Destination
Trends Pharmacol Sci. 2017 Mar;38(3):202-225. doi: 10.1016/j.tips.2016.12.005. Epub 2017 Jan 23.

Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.

Author information

1
Master of Science in Biomedical Sciences Program, Tufts University School of Medicine, Boston, MA 02111, USA.
2
Medical Scientist Training Program and Program in Neuroscience, Sackler Graduate School, Tufts University, Boston, MA 02111, USA.
3
Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA. Electronic address: alexei.degterev@tufts.edu.

Abstract

A process of regulated necrosis, termed necroptosis, has been recognized as a major contributor to cell death and inflammation occurring under a wide range of pathologic settings. The core event in necroptosis is the formation of the detergent-insoluble 'necrosome' complex of homologous Ser/Thr kinases, receptor protein interacting kinase 1 (RIPK1) and receptor interacting protein kinase 3 (RIPK3), which promotes phosphorylation of a key prodeath effector, mixed lineage kinase domain-like (MLKL), by RIPK3. Core necroptosis mediators are under multiple controls, which have been a subject of intense investigation. Additional, non-necroptotic functions of these factors, primarily in controlling apoptosis and inflammatory responses, have also begun to emerge. This review will provide an overview of the current understanding of the human disease relevance of this pathway, and potential therapeutic strategies, targeting necroptosis mediators in various pathologies.

PMID:
28126382
PMCID:
PMC5325808
DOI:
10.1016/j.tips.2016.12.005
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center